GlassScriptPhysician profile
Christa Leah Walling
NPI 1306833421
$6,515.13
in general payments reported to CMS, 2019-2025
21 companies · $838 in 2025
The $838 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $298 · 2021: $1,290 · 2022: $1,775 · 2023: $865 · 2024: $979 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,550 · Entertainment: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,549.88 |
| Entertainment | $131.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,044.15 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,546.52 | 2019-2025 | Tryptyr, Rocklatan |
| Oyster Point Pharma, INC. | $452.76 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $341.73 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $308.16 | 2024-2025 | Xdemvy |
| Coopervision INC. | $276.16 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Bausch & Lomb Americas INC. | $267.15 | 2022-2025 | Xiidra, Miebo, Infuse |
| Abbvie INC. | $229.86 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $174.84 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $151.18 | 2021-2022 | |
| Dompe US, INC. | $144.75 | 2024-2025 | Oxervate |
| Optos, INC. | $134.47 | 2020-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $112.29 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $92.53 | 2019-2023 | |
| Biotissue Holdings INC. | $60.78 | 2019-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $46.92 | 2020-2021 | |
| Lombart Brothers, INC. | $41.04 | 2019 | |
| Shire North American Group INC | $35.29 | 2019 | |
| Quidel Corporation | $21.28 | 2019 | |
| Thea Pharma INC. | $19.30 | 2023 | |
| Abb Con-Cise Optical Group LLC | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Walling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.